Infectious Disease Research Chemicals and Analytical Standards

Global life expectancy increased from 66.8 years in 2000 to 72.81 in 2021, underpinned by major investment in combating infectious diseases. However, further research and discovery are required to fight established and emerging global threats - including HIV, COVID-19, Hepatitis, antimicrobial resistant bacteria, as well as vector-borne diseases such as Malaria and Chagas disease. Our wide range of research chemicals and analytical standards can help to drive drug discovery innovation and improve the prospects of people suffering from life-threatening infectious diseases worldwide.